ghrelin
Peptideexperimental
Ghrelin is a hormone primarily produced by enteroendocrine cells of the gastrointestinal tract, especially the stomach, and is often called a "hunger hormone" because it increases the drive to eat. Blood levels of ghrelin are highest before meals when hungry, returning to lower levels after mealtimes. Ghrelin may help prepare for food intake by increasing gastric motility and stimulating the secretion of gastric acid. — Wikipedia
Clinical trial activity
39 trials · 28 clinical orgs · 0 marketing orgs
Phase 1
18
Phase 2
14
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2003 (NCT00512525)
Timeline
Indications
Studied for
- Aging · Phase 2
- Alcohol Drinking · Phase 2
- Alcoholism · Phase 2
- Brain Concussion · Phase 2
- Brain Injuries, Traumatic · Phase 2
- Cachexia · Phase 2
- Diabetes Mellitus, Type 2 · Phase 1
- Frailty · Phase 2
- Healthy Volunteers · Phase 1
- Heart Failure · Phase 1/Phase 2
- Insulin Resistance · Phase 1
- Ischemic Stroke · Phase 2
- Magnetic Resonance Imaging · Phase 2
- Major Depressive Disorder · Phase 1/Phase 2
- Neoplasms · Phase 3
- Obesity · Phase 1
- Peripheral Arterial Disease · Phase 2
- Smoking Cessation · Early Phase 1
- Sports Medicine · Phase 1
Mechanism of action
- Ghrelin receptorAGONIST
GHSR agonist
Chemistry & pharmacology
Loading structure…
SMILES
CCCCCCCC(=O)OC[C@H](NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O- Mol. weight
- 3314.85 g/mol
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaGhrelin ↗
- ChEMBLCHEMBL500468 ↗
Also known as
- acyl ghrelin
- acyl-ghrelin
- desacylghrelin
- des-acyl ghrelin
- desacyl ghrelin
- desacyl ghrelin
- des-n-octanoyl ghrelin
- gastric mltrp
- ghrelin
- ghrelin
- ghrelin
- ghrelin, des-n-octanoyl
- human acylated ghrelin
- human acylated ghrelin
- lenomorelin
- lenomorelin
- sun11031
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06576440 | N/A | Sep 2, 2024 | University of Tuebingen |
| NCT05726240 | Phase 2 | Oct 31, 2023 | Rijnstate Hospital |
| NCT05318924 | Phase 1/Phase 2 (Phase 2) | Feb 21, 2022 | German Research Foundation, University of Tuebingen |
| NCT05189353 | N/A | Jan 14, 2022 | University of Copenhagen |
| NCT04558346 | Phase 2 | Oct 20, 2020 | University of Kansas |
| NCT04377126 | Phase 2 | May 20, 2020 | National Institute on Aging (NIA), Northwestern University |
| NCT04055025 | N/A | Sep 30, 2019 | University of Copenhagen |
| NCT03198143 | Phase 1 | Mar 31, 2019 | Duke University |
| NCT02440061 | Phase 1 | May 1, 2017 | Duke University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| NCT02913703 | Phase 1 | Jan 11, 2017 | Duke University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| NCT02953587 | Phase 1 | Sep 1, 2016 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Vanderbilt University |
| NCT03358355 | Phase 1/Phase 2 (Phase 2) | Jun 7, 2016 | Northwestern University |
| NCT02690987 | Early Phase 1 (Phase 1) | Aug 1, 2015 | University of London |
| NCT02528422 | Phase 1 | May 1, 2015 | Aarhus University |
| NCT02271282 | Phase 1 | Dec 1, 2014 | Mayo Clinic |
| NCT02272647 | Phase 1 | Dec 1, 2014 | Mayo Clinic |
| NCT01898611 | Phase 2 | Jul 1, 2013 | University of Pennsylvania |
| NCT01729299 | N/A | Apr 1, 2013 | National Institutes of Health (NIH), University of Cincinnati |
| NCT05277415 | Phase 1/Phase 2 (Phase 2) | Feb 17, 2013 | Karolinska Institute |
| NCT01833078 | Phase 2 | Feb 1, 2013 | University of Pennsylvania |
Showing 20 of 39 trials
Page 1 / 2
Organizations
Research & Development (28)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aarhus University | Academic/Hospital | 7 | 7 | 2 | 2003 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Government | 5 | 0 | 2 | 2011 |
| University of Pennsylvania | Academic/Hospital | 4 | 4 | 1 | 2007 |
| Duke University | Academic/Hospital | 3 | 3 | 1 | 2017 |
| Vanderbilt University | Academic/Hospital | 3 | 3 | 1 | 2011 |
| German Research Foundation | Academic/Hospital | 2 | 0 | 2 | 2004 |
| Mayo Clinic | Academic/Hospital | 2 | 2 | 1 | 2014 |
| Northwestern University | Academic/Hospital | 2 | 2 | 1 | 2016 |
| University of Cincinnati | Academic/Hospital | 2 | 2 | 1 | 2011 |
| University of Copenhagen | Academic/Hospital | 2 | 2 | 1 | 2019 |
| University of Tuebingen | Academic/Hospital | 2 | 2 | 2 | 2022 |
| Bachem | For profit | 1 | 0 | 1 | 2009 |
| Brown University | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Cantonal Hospital of St. Gallen | Academic/Hospital | 1 | 1 | 1 | 2009 |
| Daiichi Sankyo | For profit | 1 | 1 | 1 | 2008 |
| Karolinska Institute | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Max Planck Institute | Academic/Hospital | 1 | 1 | 1 | 2004 |
| Medical Research Council | Government | 1 | 0 | 1 | 2003 |
| Monash University | Academic/Hospital | 1 | 1 | 1 | 2009 |
| National Institute on Aging (NIA) | Government | 1 | 0 | 1 | 2020 |
28 organizations
Page 1 / 2